Home > Insider Trading > Trevi Therapeutics Inc.

Trevi Therapeutics Inc. (TRVI)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Oppenheimer Raises Price Target for Trevi Therapeutics by $3

In a research note, the analyst informs investors that Haduvio's favorable topline Phase 2b news strengthens the company's case for addressing idiopathic pulmonary fibrosis persistent cough, for which...

Keep Reading →

June 3rd, 2025 - News

Oppenheimer Boosts Trevi Therapeutics (TRVI) PT to $23, Cites Positive Haduvio Trial Results

On Tuesday, Oppenheimer increased its price target for Trevi Therapeutics Inc. (NASDAQ:TRVI) to $23 from $20, while maintaining an Outperform rating.

Keep Reading →

June 3rd, 2025 - News

H.C. Wainwright Initiates Coverage of Trevi Therapeutics (TRVI) With Buy Rating

On May 28, Oren Livnat, an analyst from H.C. Wainwright initiated coverage of Trevi Therapeutics, Inc. (NASDAQ:TRVI) with a Buy rating and a $21 price target.

Keep Reading →

May 29th, 2025 - News

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q1 2025 Earnings Call Transcript

Operator: Good afternoon and welcome to the Trevi Therapeutics First Quarter 2025 Earnings Conference Call. At this time, all participants will be in a listen-only mode.

Keep Reading →

May 13th, 2025 - News Transcripts

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q4 2024 Earnings Call Transcript

Operator: Good afternoon and welcome to the Trevi Therapeutics Fourth Quarter and Year End 2024 Earnings Conference Call. At this time, all participants will be in listen-only mode.

Keep Reading →

March 22nd, 2025 - News Transcripts

Why Trevi Therapeutics (TRVI) Is Advancing Today

With Trevi poised to soon announce data from a trial of its Haduvio drug as a treatment for refractory chronic cough (RCC), Stifel predicts that the readout will be positive.

Keep Reading →

February 20th, 2025 - Market Movers News

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q3 2024 Earnings Call Transcript

Operator: Good afternoon, and welcome to the Trevi Therapeutics Third Quarter 2024 Earnings Conference Call. At this time, all participants will be in listen-only mode.

Keep Reading →

November 8th, 2024 - News Transcripts

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q2 2024 Earnings Call Transcript

Operator: Good afternoon. And welcome to the Trevi Therapeutics Second Quarter 2024 Earnings Conference Call. At this time, all participants will be in a listen-only mode.

Keep Reading →

August 12th, 2024 - News Transcripts

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q1 2024 Earnings Call Transcript

Operator: Good afternoon, and welcome to the Trevi Therapeutics First Quarter 2024 Earnings Conference Call. At this time, all participants will be in a listen-only mode.

Keep Reading →

May 13th, 2024 - News Transcripts